StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Anika Therapeutics's price to book ratio was 1.4× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.8× to 2.0×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.4×+0.4
2025Dec 31, 20250.9×−0.4
2024Dec 31, 20241.3×+0.1
2023Dec 29, 20231.2×−0.3
2022Dec 30, 20221.5×−0.3
2021Dec 31, 20211.8×−0.5
2020Dec 31, 20202.3×−0.4
2019Dec 31, 20192.6×+0.8
2018Dec 31, 20181.9×−1.2
2017Dec 29, 20173.1×−0.2
2016Dec 30, 20163.3×+0.5
2015Dec 31, 20152.9×−0.7
2014Dec 31, 20143.6×−0.7
2013Dec 31, 20134.2×+2.9
2012Dec 31, 20121.3×−0.1
2011Dec 30, 20111.4×+0.5
2010Dec 31, 20100.9×–

More Anika Therapeutics figures

See a number that looks wrong?